Table 1. Clinical Data for Patients'... | American Society of Hematology

Table 1.

Clinical Data for Patients' Samples Used in This Study

Patient No.^-150	Age	Sex	PB WBC Count (×10⁹/L)	Prior Treatment
2	26	M	395	None
3	26	M	45	Hydroxyurea × 2 mos
4	63	M	58	None
5	50	F	160	None
6	48	M	135	None
7	54	M	132	None
10	51	F	135	None
12	67	F	189	None
13	72	M	218	None
14	63	M	123	None
15	37	M	82	Hydroxyurea × 1 wk
16	34	F	120	None
17	63	M	87	One 4-wk course of busulphan 30 mos previously

Patient No.^-150	Age	Sex	PB WBC Count (×10⁹/L)	Prior Treatment
2	26	M	395	None
3	26	M	45	Hydroxyurea × 2 mos
4	63	M	58	None
5	50	F	160	None
6	48	M	135	None
7	54	M	132	None
10	51	F	135	None
12	67	F	189	None
13	72	M	218	None
14	63	M	123	None
15	37	M	82	Hydroxyurea × 1 wk
16	34	F	120	None
17	63	M	87	One 4-wk course of busulphan 30 mos previously

Abbreviations: M, male; F, female.

All patients had Ph⁺ CML and were in chronic phase at the time the sample was taken.